ABSTRACT

Background: Musculoskeletal disorders (MSDs) are injuries or pain in the human musculoskeletal system. MSDs arise from a sudden exertion, repetitive strain or from repeated exposure to vibration. The main aim is to study the trends of analgesic utilization in common musculoskeletal disorders in geriatric population and to evaluate the prescribing trends of analgesics in common musculoskeletal disorders in geriatric population. Methodology: A retrospective study was conducted in the Orthopaedic department in a tertiary care setting. The study was carried out for a period of 6 months in which data from January 2018-April 2022 was collected. Patients who satisfied both exclusion and inclusion criteria were selected for the study. Results: The majority of patients with MSDs were in the age group of 70-79 years. It is evident from the study that MSD was high in females (51.51%). Rheumatoid arthritis (37%) was found to be the most common among MSDs. Most common risk factors associated with MSD were female gender (51.51%). In route of administration of drugs, oral route was found to be more frequently used. Hypertension was the most commonly associated comorbidities for MSD in geriatric population. Most commonly prescribed analgesic drug was paracetamol. In this study, combination therapy was the most commonly prescribed (51.52%) followed by monotherapy (48.48%). Combination therapy was the most commonly used than single therapy. Paracetamol+Tramadol combination was most commonly used. On comparison with Opioids, Non-opioids were the most frequently used class of drug. Conclusion: The study finding suggested that the majority of patients with MSD were in the age group of 70-79 years (old old). It was evident from the study that MSD was high in females. Most common risk factor associated with MSD was hypertension. Most common disease was found to be rheumatoid arthritis .The study concludes that Paracetamol was the most commonly prescribed drug for MSDs. Keywords: Musculoskeletal disorder, Analgesic, risk factor, comorbidities
Publication date: 01/08/2023

https://ijbpas.com/pdf/2023/August/MS_IJBPAS_2023_7295.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2023/12.8.7295